Author:
Mallidi Srivalleesha,Khan Amjad P.,Liu Hui,Daly Liam,Rudd Grant,Leon Paola,Khan Shakir,Hussain Bilal M. A.,Hasan Syed A.,Siddique Shahid A.,Akhtar Kafil,August Meredith,Troulis Maria,Cuckov Filip,Celli Jonathan P.,Hasan Tayyaba
Abstract
Abstract
Oral cancer prevalence is increasing at an alarming rate worldwide, especially in developing countries which lack the medical infrastructure to manage it. For example, the oral cancer burden in India has been identified as a public health crisis. The high expense and logistical barriers to obtaining treatment with surgery, radiotherapy and chemotherapy often result in progression to unmanageable late stage disease with high morbidity. Even when curative, these approaches can be cosmetically and functionally disfiguring with extensive side effects. An alternate effective therapy for oral cancer is a light based spatially-targeted cytotoxic therapy called photodynamic therapy (PDT). Despite excellent healing of the oral mucosa in PDT, a lack of robust enabling technology for intraoral light delivery has limited its broader implementation. Leveraging advances in 3D printing, we have developed an intraoral light delivery system consisting of modular 3D printed light applicators with pre-calibrated dosimetry and mouth props that can be utilized to perform PDT in conscious subjects without the need of extensive infrastructure or manual positioning of an optical fiber. To evaluate the stability of the light applicators, we utilized an endoscope in lieu of the optical fiber to monitor motion in the fiducial markers. Here we showcase the stability (less than 2 mm deviation in both horizontal and vertical axis) and ergonomics of our applicators in delivering light precisely to the target location in ten healthy volunteers. We also demonstrate in five subjects with T1N0M0 oral lesions that our applicators coupled with a low-cost fiber coupled LED-based light source served as a complete platform for intraoral light delivery achieving complete tumor response with no residual disease at initial histopathology follow up in these patients. Overall, our approach potentiates PDT as a viable therapeutic option for early stage oral lesions that can be delivered in low resource settings.
Funder
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Gupta, N. et al. Changing Trends in oral cancer - a global scenario. Nepal J Epidemiol 6, 613–619 (2016).
2. Shield, K. D. et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA: A Cancer Journal for Clinicians 67, 51–64 (2016).
3. Rigual, N. R. et al. Photodynamic therapy for head and neck dysplasia and cancer. Arch. Otolaryngol. Head Neck Surg. 135, 784–788 (2009).
4. Hopper, C., Kübler, A., Lewis, H., Tan, I. B. & Putnam, G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int. J. Cancer 111, 138–146 (2004).
5. D’Cruz, A. K., Robinson, M. H. & Biel, M. A. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 26, 232–240 (2004).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献